• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Blood glucose monitor dev Intuity Medical raises $26m

May 30, 2019 By Fink Densford

Intuity Medical

Blood glucose monitor maker Intuity Medical has raised approximately $26.3 million in a new round of mixed financing, according to a recently posted SEC filing.

Fremont, Calif.-based Intuity Medical is developing the Pogo all-in-one automatic blood glucose monitoring system. The Pogo platform incorporates test strips, lancets and a lancing device into a compact meter and cartridge system, the company said.

The Pogo system is designed to automatically lance the users finger, collect the blood sample and provide test results in a single step, according to the company’s website.

Money in the round came from 15 unnamed investors, with the first date of sale noted as having occurred on May 2, according to the filing.

The company is looking to raise an additional $10 million in the round, which would bring the total raised up to approximately $36.3 million.

Intuity Medical offered a combination of equity, debt, options and securities available upon exercise of options and warrants in the offering, according to the SEC filing.

The company has not yet officially announced how it plans to spend funds raised in the round.

In January 2017, Intuity Medical said that it added another $15 million to the $40 million Series C round it reported a year earlier, bringing the round’s total to $55 million.

Filed Under: Business/Financial News, Diabetes, Featured, Wall Street Beat Tagged With: intuitymedical

IN CASE YOU MISSED IT

  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor
  • Medtronic to separate Diabetes business unit

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS